Filter Results:
(611)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Sort by
- 11 Oct 2006
- Research & Ideas
The Success of Reverse Leveraged Buyouts
business press and savvy business experts such Warren Buffett. It didn’t help when one of the most publicized RLBOs—Refco—collapsed in 2005 shortly after its initial public offering. And on September 21, a 70-million share offering for View Details
- 27 Sep 2011
- First Look
First Look: September 27
Even in the absence of national health coverage, the United States became the world's largest prescription drug market and emerged as the global leader in new drug research and testing. With health benefits... View Details
Keywords: Sean Silverthorne
- 26 Sep 2006
- First Look
First Look: September 26, 2006
the pandemic. Most have not been very successful. An examination of three strategies for distributing antiretroviral drugs (ARVs) to patients in three countries on three continents, Africa, Asia, and South America, suggests a customer... View Details
Keywords: Sean Silverthorne
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
the United States, the Federal Drug Administration this week advised states to pause the use of the Johnson & Johnson vaccine after six women developed a rare blood-clotting disorder, raising new concerns about total vaccine supply.... View Details
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
with revenue expectations of $1 billion in 2015. At the time of the acquisition, AbbVie received more than 60% of its sales from the drug Humira, a biologic agent used to treat several autoimmune diseases and malignancies. However, Humira... View Details
Keywords: Sean Silverthorne
- 19 Nov 2014
- HBS Case
Marketing Marijuana
something that hadn't been done in 81 years—make an illegal drug legal. “They do not need to buy it at a fancy store—they'll go to a back alley basement shop as long as the product delivers” Of course, the question remains: How will state... View Details
- 05 Jul 2004
- Research & Ideas
Radical Change, Entrepreneurial Opportunity
tightly coupled relationships with customers to engage in trials of different product concepts, producers and users can jointly learn about and make sense of the new technology. For instance, Surface Logix, a firm with highly sophisticated, flexible technology called... View Details
- 22 Mar 2011
- First Look
First Look: March 22
successful convenience foods business to more countries. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/511070-PDF-ENG PureCircle David E. Bell and Aldo SesiaHarvard Business School Case 510-032 In December 2008, the U.S. Food and View Details
Keywords: Sean Silverthorne
- 26 Apr 2004
- Research & Ideas
A Clear Eye for Innovation
series of contact-lens products, introduced a drug for treating age-related macular degeneration, pioneered a new lens-manufacturing process that dramatically reduced production costs, and overtook J&J in some market segments. The... View Details
- 15 Feb 2000
- Lessons from the Classroom
Delivering Information Services: A 30-Year Perspective
IPO in 1990 to a $10-billion company today, with a market value of close to $140 billion! I'm also doing research for a case on Drugstore.com, which is essentially a drug store "built" on the Internet. It's getting ready to... View Details
Keywords: by Staff
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare diseases, has attracted interest... View Details
Keywords: Sean Silverthorne
- 13 Jan 2009
- First Look
First Look: January 13, 2009
and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Martha Lagace
- 07 Aug 2006
- Research & Ideas
Whatever Happened to Caveat Emptor?
basic material needs to concerns about the safety and quality of these products. When products did fail—as happened dramatically in the late 1950s with the antinausea drug Thalidomide—such cases became the focus of aggressive consumer... View Details
- 29 Jan 2013
- First Look
First Look: Jan. 29
facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging... View Details
Keywords: Sean Silverthorne
- 21 Jul 2015
- First Look
First Look: July 21, 2015
new drug markets. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=49384 Cases & Course Materials Harvard Business School Case 715-438 The Transformation of NCR During his tenure as CEO since 2005, Bill Nuti... View Details
Keywords: Sean Silverthorne
- 30 Oct 2007
- First Look
First Look: October 30, 2007
Changing Context of Pharmaceutical Risk Mitigation Author:Arthur A. Daemmrich Periodical:Pharmacy in History 49, no. 2 (2007): 61-75 Abstract In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side... View Details
Keywords: Sean Silverthorne
- 22 Aug 2006
- First Look
First Look: August 22, 2006
805-067 Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to... View Details
Keywords: Martha Lagace
- 17 Sep 2001
- Research & Ideas
Why E-commerce Didn’t Die With the Fall of Webvan
drugs for chronic conditions—from pharmacies to a combination of direct mail and telephone. The idea was that if you have a chronic condition, you're in a replenishment mode. You have to fill the prescription regularly over a number of... View Details
- 12 Nov 2024
- HBS Case
Inside One Startup's Journey to Break Down Hiring (and Funding) Barriers
mouths have an opportunity to do something like Harley’s doing?” A prison conviction leads to multiple employment rejections After losing his father at age 15, Blakeman fell into hard drug use. After he was incarcerated in a Georgia... View Details
- 15 Apr 2014
- First Look
First Look: April 15
from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was marketed as a diagnostic and preventative tool and that it was subject to... View Details
Keywords: Sean Silverthorne